Trade Mark Journal No.2024/050 13 December 2024

UK00004129436 26 November 2024 (5)

REXFLUVA

International priority date claimed: 20 November 2024 (Benelux Office for Intellectual Property (BOIP)) (1514643)
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines .

GlaxoSmithKline Biologicals SA

Representative: Legal Brand Protection